From: The effect of using blood culture bottle of bronchoalveolar larvage fluid in pneumonia
Variables | N (%) |
---|---|
Age (years) | |
Median (range) | 70.5 (37–93) |
Male | 27 (69.2) |
Category of pneumonia | |
CAP | 21 (53.8) |
HCAP | 6 (15.4) |
HAP & VAP | 12 (30.8) |
Comorbidities | |
Diabetes mellitus | 5 (12.5) |
Solid organ malignancy | 11 (27.5) |
Hematologic malignancy | 2 (5) |
Chronic respiratory disease | 8 (20.5) |
HIV infection | 1 (2.6) |
Antibiotics started on admission | 38 (97.4) |
Antibiotics started within 24 h before BAL | 13 (33.3) |
Duration of antibiotics before bronchoscopy (days), mean ± SD | 5.8 ± 6.4 |
Leukocytes (per mm3), mean ± SD | 11,226 ± 5056 |
C-reactive protein (mg/dL), mean ± SD | 11.74 ± 8.24 |
Pneumonia outcome | |
Improved | 31 (77.5) |
Transferred out | 1 (2.5) |
Died | 7 (17.5) |